概括
在接受心脏导管治疗的患者中,高血压曼尼醇显著增加了39%的冠状动脉血流. 这表明曼尼托在治疗冠状动脉疾病方面具有潜在的治疗价值.
科学领域:
- 心脏病学 心脏病学
- 心血管生理学心血管生理学
- 药理学 药理学 是一个学科.
背景情况:
- 血清度会影响心血管血液动力学.
- 高血压剂在临床上使用,但它们对冠状动脉循环的特定作用需要进一步阐明.
研究的目的:
- 为了研究血动力学和冠状动脉血流效应的小增加的血清度诱导高压曼尼托尔.
- 评估心脏导管治疗的患者,包括冠状动脉疾病患者的这些影响.
主要方法:
- 接受心脏导管治疗的20名患者接受了高压曼尼托尔,以增加大约10mOsm的血清度.
- 测量包括全身动脉压,左心室压力 (LV dp/dt),左心室末端透气压,心输出,心率和血红素.
- 在服用曼尼托尔之前和之后评估了冠状动脉血流量.
主要成果:
- 曼尼托尔的使用导致了平均系统动脉压的显著增加,最大的LV dp/dt,左心室末端透气压和心脏输出.
- 没有观察到心率或血红素的显著变化.
- 观察到冠状动脉血流量显著增加39%,无论冠状动脉疾病的严重程度如何.
结论:
- 超性曼尼托尔诱导系统和心室血动力学显著增加,并显著增强冠状动脉血流.
- 冠状动脉血流的大幅增加表明,曼尼托在冠状动脉疾病患者中具有潜在的治疗应用.
- 需要进一步的研究来探索曼尼托在治疗冠状动脉疾病中的生理意义和临床实用性.
相关概念视频
Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...


